A randomized , double-masked , crossover trial was conducted in patients with asthma on controller medications with PC20 of 8 mg/mL or lower ( n = 64 ) to evaluate the effect of high-dose ( 1,000 g/d ) vs low-dose ( 250 g/d ) fluticasone for 4 weeks on PC20 .